Corcept Therapeutics CORT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $47.34M-52.5% | $99.65M-6.1% | $106.11M-20.6% | $133.66M-0.3% | $133.99M-5.1% | ||
| $1.29M+11.8% | $1.15M+0.7% | $1.14M-2.5% | $1.17M+2.9% | $1.14M+43.0% | ||
| $85.71M+1.4% | $84.5M+4.9% | $80.53M+9.2% | $73.75M+5.5% | $69.94M+14.0% | ||
| $120.45M-15.2% | $142M-13.2% | $163.61M-10.3% | $182.42M+1.7% | $179.31M-9.6% | ||
| $308K+46.0% | $211K-25.2% | $282K-85.3% | $1.92M-15.8% | $2.28M+4.8% | ||
| —— | —— | $17.24M+142% | -$41.44M+75.9% | -$171.76M+3.3% | ||
| $145.48M-15.9% | $172.92M0.0% | $172.92M+21.6% | $142.16M+234% | $42.62M+172% | ||
| -$179.8M+18.4% | -$220.37M-13.8% | -$193.71M-15.0% | -$168.39M-149% | -$67.61M-138% | ||
| —— | —— | —— | —— | -$59.93M-660% | ||
| $120.15M-15.3% | $141.79M-13.2% | $163.32M-9.5% | $180.5M+2.0% | $177.03M-9.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Corcept Therapeutics generate?
- Corcept Therapeutics (CORT) generated $120.5M in operating cash flow over the trailing twelve months.
- What is Corcept Therapeutics's free cash flow?
- After $308.0K of capital expenditures, Corcept Therapeutics's free cash flow was $120.1M over the trailing twelve months, down 32.1% year over year.
- Where does Corcept Therapeutics's cash flow data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
